NPR

Johnson & Johnson Executive Says Vaccine Works Where It Counts: Preventing Deaths

The Johnson & Johnson COVID-19 vaccine, pictured in December, is 66% effective at preventing moderate and severe disease. But Dr. Paul Stoffels of Johnson & Johnson says what matters more is preventing hospitalizations and deaths, which it did completely.

Dr. Paul Stoffels, the chief scientific officer at Johnson & Johnson, told NPR on Friday that the topline results from the company's coronavirus vaccine study fail to tell the full story about just how effective it actually is.

Johnson & Johnson said that 28 days after vaccination, its vaccine is 66% effective in preventing moderate to severe cases of COVID-19. But Stoffels says that Johnson & Johnson's vaccine is very effective where it matters most: preventing hospitalizations and deaths.

"We showed that there was an 85% efficacy against severe disease and a complete protection against hospitalization and

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min readAmerican Government
Trump's Immunity Arguments And The Experiences Of The Justices Who Might Support It
Five of the six conservatives spent much of their lives in the Beltway, working in the White House and Justice Department, seeing their administrations as targets of unfair harassment by Democrats.
NPR2 min read
More Than 500 People Have Been Arrested At Pro-Palestinian Protests At Colleges
Students and others are protesting Israel's war against Hamas in Gaza and, in some cases, their school's investments in Israel. Presidents at several schools face calls to resign amid the protests.
NPR8 min read
Whither The West Coast Gangsta?
A familiar rap character, the Cali hustler cruising in a low-rider, has faded in the 21st century. On new albums by G Perico, Mozzy and Gangrene, that figure is alive and well, living in the margins.

Related Books & Audiobooks